Cargando…

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine

BACKGROUND: The aim of this study is to evaluate the impact of coexistence of metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) on the estimated cardiovascular risk as calculated using the United Kingdom Prospective Diabetic Study risk engine (UKPDS-RE) and also to determine the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogedengbe, O Stephen, Ezeani, Ignatius U, Chukwuonye, Ijezie I, Anyabolu, Ernest N, Ozor, Ikemefuna I, Eregie, Aihanuwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577267/
https://www.ncbi.nlm.nih.gov/pubmed/26396537
http://dx.doi.org/10.2147/DMSO.S69199
_version_ 1782390961194663936
author Ogedengbe, O Stephen
Ezeani, Ignatius U
Chukwuonye, Ijezie I
Anyabolu, Ernest N
Ozor, Ikemefuna I
Eregie, Aihanuwa
author_facet Ogedengbe, O Stephen
Ezeani, Ignatius U
Chukwuonye, Ijezie I
Anyabolu, Ernest N
Ozor, Ikemefuna I
Eregie, Aihanuwa
author_sort Ogedengbe, O Stephen
collection PubMed
description BACKGROUND: The aim of this study is to evaluate the impact of coexistence of metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) on the estimated cardiovascular risk as calculated using the United Kingdom Prospective Diabetic Study risk engine (UKPDS-RE) and also to determine the impact of the coexistence of MS and T2DM on the 10-year risk of developing coronary heart disease and stroke. METHODOLOGY: This is a cross-sectional study in which convenience sampling technique was used to recruit 124 consecutive persons with T2DM and 96 controls using a questionnaire administered technique. The World Health Organization (WHO) criterion was used to define MS and the UKPDS-RE was used to identify persons with increased risk for stroke and those with increased risk for coronary heart disease. The data obtained were analyzed using SPSS version 16. Statistical comparisons were made with chi-square for comparison of proportions. A P-value of less than 0.05 was taken as statistically significant. RESULTS: Fifteen subjects were identified as having an increased 10-year risk for stroke and ten as having an increased risk for a coronary event. The odds of a T2DM subject with MS having an increased risk for stroke compared with a T2DM subject without MS was 0.9579≈1 while the odds of a T2DM subject with MS developing an increased risk for a coronary event compared with a T2DM subject without MS was =3.451≈3. CONCLUSION: MS was more common in subjects with T2DM compared with controls (irrespective of the diagnostic criteria used) and MS appears to increase the risk of a coronary event in subjects with T2DM by threefold. Also from this study, MS did not appear to cause an additional increase in the risk of stroke in subjects with T2DM.
format Online
Article
Text
id pubmed-4577267
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-45772672015-09-22 Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine Ogedengbe, O Stephen Ezeani, Ignatius U Chukwuonye, Ijezie I Anyabolu, Ernest N Ozor, Ikemefuna I Eregie, Aihanuwa Diabetes Metab Syndr Obes Original Research BACKGROUND: The aim of this study is to evaluate the impact of coexistence of metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) on the estimated cardiovascular risk as calculated using the United Kingdom Prospective Diabetic Study risk engine (UKPDS-RE) and also to determine the impact of the coexistence of MS and T2DM on the 10-year risk of developing coronary heart disease and stroke. METHODOLOGY: This is a cross-sectional study in which convenience sampling technique was used to recruit 124 consecutive persons with T2DM and 96 controls using a questionnaire administered technique. The World Health Organization (WHO) criterion was used to define MS and the UKPDS-RE was used to identify persons with increased risk for stroke and those with increased risk for coronary heart disease. The data obtained were analyzed using SPSS version 16. Statistical comparisons were made with chi-square for comparison of proportions. A P-value of less than 0.05 was taken as statistically significant. RESULTS: Fifteen subjects were identified as having an increased 10-year risk for stroke and ten as having an increased risk for a coronary event. The odds of a T2DM subject with MS having an increased risk for stroke compared with a T2DM subject without MS was 0.9579≈1 while the odds of a T2DM subject with MS developing an increased risk for a coronary event compared with a T2DM subject without MS was =3.451≈3. CONCLUSION: MS was more common in subjects with T2DM compared with controls (irrespective of the diagnostic criteria used) and MS appears to increase the risk of a coronary event in subjects with T2DM by threefold. Also from this study, MS did not appear to cause an additional increase in the risk of stroke in subjects with T2DM. Dove Medical Press 2015-09-18 /pmc/articles/PMC4577267/ /pubmed/26396537 http://dx.doi.org/10.2147/DMSO.S69199 Text en © 2015 Ogedengbe et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Ogedengbe, O Stephen
Ezeani, Ignatius U
Chukwuonye, Ijezie I
Anyabolu, Ernest N
Ozor, Ikemefuna I
Eregie, Aihanuwa
Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
title Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
title_full Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
title_fullStr Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
title_full_unstemmed Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
title_short Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
title_sort evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the ukpds risk engine
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577267/
https://www.ncbi.nlm.nih.gov/pubmed/26396537
http://dx.doi.org/10.2147/DMSO.S69199
work_keys_str_mv AT ogedengbeostephen evaluatingtheimpactoftype2diabetesmellitusoncardiovascularriskinpersonswithmetabolicsyndromeusingtheukpdsriskengine
AT ezeaniignatiusu evaluatingtheimpactoftype2diabetesmellitusoncardiovascularriskinpersonswithmetabolicsyndromeusingtheukpdsriskengine
AT chukwuonyeijeziei evaluatingtheimpactoftype2diabetesmellitusoncardiovascularriskinpersonswithmetabolicsyndromeusingtheukpdsriskengine
AT anyaboluernestn evaluatingtheimpactoftype2diabetesmellitusoncardiovascularriskinpersonswithmetabolicsyndromeusingtheukpdsriskengine
AT ozorikemefunai evaluatingtheimpactoftype2diabetesmellitusoncardiovascularriskinpersonswithmetabolicsyndromeusingtheukpdsriskengine
AT eregieaihanuwa evaluatingtheimpactoftype2diabetesmellitusoncardiovascularriskinpersonswithmetabolicsyndromeusingtheukpdsriskengine